To learn more about our ongoing clinical trials or to find out if a trial is enrolling patients in your area, please visit www.clinicaltrials.gov.
|Candidates||Phase||Study Number||Study Title|
|BLU-5937||Phase 3||NCT05599191||CALM-1 – Refractory Chronic Cough|
|BLU-5937||Phase 3||NCT05600777||CALM-2 – Refractory Chronic Cough|
At this time, BELLUS’ investigational therapy is not available on an expanded access or right-to-try basis for new patients. In the event BELLUS decides to consider expanded access or right-to-try use, the Company will evaluate and respond to each request that it receives on a case-by-case basis. For more information on our investigational therapy and ongoing clinical trials, please visit bellushealth.com/pipeline/blu-5937 or clinicaltrials.gov.